Preoperative Fine Needle Aspiration from Human Breast Cancer is a Valuable Sampling Material for Progesterone Receptor and Cytometric Dna Analysis

References

• Borgå M Fernö, Idvall I. Estrogen receptor enzyme immunoassay in fine-needle aspirates from human breast cancer. Acta Oncol 1989; 28: 187–91
   PubMedGoogle Scholar
• Frigo B., Pilotti S., Zurrida S., Ermellino L., Manzari A., Rilke F. Analysis of estrogen and progesterone receptors on preoperative fine-needle aspirates. Breast Cancer Res Treat 1995; 33: 179–84
   PubMedGoogle Scholar
• Marrazzo A., Russo A., Bazan V., Taormina P., Lupo F., Bazan P. Immunocytochemical determination of estrogen and progesterone receptors and flow cytometric DNA analysis of breast cancer on fine needle aspirates. Anticancer Res 1993; 13: 2435–40
   PubMedGoogle Scholar
• Briffod M., Spyratos F., Tubiana-Hulin M. Sequential cytopunctures during preoperative chemotherapy for primary breast carcinoma. Cytomorphologic changes, initial tumor ploidy, and tumor progression. Cancer 1989; 63: 631–7
   PubMed Web of Science ®Google Scholar
• Davey D. D., Banks E. R., Jennings D., Powell D. E. Comparison of nuclear grade and DNA cytometry in breast carcinoma aspirates to histologic grade in excised cancers. Am J Clin Pathol 1993; 99: 708–13
   PubMedGoogle Scholar
• Eliasen C. A., Opitz L. M., Vamvakas E. C. Flow cytometric analysis of DNA ploidy and S-phase fraction in breast cancer using cells obtained by ex vivo fine-needle aspiration: an optimal method for sample collection. Modern Pathology 1991; 4: 196–200
   PubMedGoogle Scholar
• Fuhr J. E., Kattine A. A., Nelson S. Evaluation of in vivo breast fine needle aspirates by flow cytometry: an efficacy study. J Natl Cancer Inst 1992; 84: 1272–6
   PubMedGoogle Scholar
• Levack P. A., Mullen P., Anderson T. J., Miller W. R., Forrest A. P. M. DNA analysis of breast tumour fine needle aspirates using flow cytometry. Br J Cancer 1987; 56: 643–6
   PubMedGoogle Scholar
• Palmer J. O., McDivitt R. W., Stone K. R., Rudloff M. A., Gonzalez J. G. Flow cytometric analysis of breast needle aspirates. Cancer 1988; 62: 2387–91
   PubMedGoogle Scholar
• Fallenius A. G., Auer G. U., Carstensen J. M. Prognostic significance of DNA measurements in 409 consecutive breast cancer patients. Cancer 1988; 62: 331–41
   PubMed Web of Science ®Google Scholar
• Nordenskjöld B., Löwhagen T., Westerberg H., Zajicek J. 3H-thymidine incorporation into mammary carcinoma cells obtained by needle aspiration before and during endocrine therapy. Acta Cytol 1976; 20: 137–43
   PubMed Web of Science ®Google Scholar
• Ljung B-M, Chew K., Deng G., Matsumura K., Waldman F., Smith H. Fine needle aspiration techniques for the characterization of breast cancers. Cancer 1994; 74: 1000–5
   PubMedGoogle Scholar
• Bozzetti C., Nizzoli R., Naldi N. Fine-needle aspiration technique for the concurrent immunocytochemical evaluation of multiple biologic parameters in primary breast carcinoma. Breast Cancer Res Treat 1994; 32: 221–8
   PubMedGoogle Scholar
• Idvall I., Fernö M, Sigurdsson H., Åkerman M., Killander D. Fine needle aspiration cytology of breast carcinoma-a preoperative prognostic tool. The Breast 1995; 4: 189–95
   Google Scholar
• Robinson I. A., McKee G., Nicholson A. Prognostic value of cytological grading of fine-needle aspirates from breast carcinomas. Lancet 1994; 343: 947–9
   PubMedGoogle Scholar
• Remvikos Y., Magdelenat H., Zajdela A. DNA flow cytometry applied to fine needle sampling of human breast cancer. Cancer 1988; 61: 1629–34
   PubMedGoogle Scholar
• Spyratos F., Briffod M., Gentile A., Brunet M., Brault C. Desplaces A. Flow cytometric study of DNA distribution in cytopunctures of benign and malignant breast lesions. Analyt Quant Cytol 1987; 9: 485–94
   Google Scholar
• Hedley D. W., Clark G. M., Cornelisse C. J., Killander D., Kute T., Merkel D. Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast. Cytometry 1993; 14: 482–5
   PubMedGoogle Scholar
• Sigurdsson H., Baldetorp B., Borg Å. Indicators of prognosis in node-negative breast cancer. N Engl J Med 1990; 322: 1045–53
   PubMed Web of Science ®Google Scholar
• Franzen S., Zajicek J. Aspiration biopsy diagnosis of palpable lesions of the breast: a critical review of 3479 consecutive biopsies. Acta Radiol 1968; 7: 241–62
   Web of Science ®Google Scholar
• Burton K. A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem 1956; 62: 23–315
   Google Scholar
• Schneider W. C. Phosphorous compounds in animal tissues. I. Extraction and estimation of desoxypentose nucleic acid and of pentose nucleic acid. J Biol Chem 1945; 161: 293–303
   Google Scholar
• Vindeløv L. L., Christensen I. J., Nissen N. I. Standardization of high resolution flow cytometric DNA analysis by the simultaneous use of chicken and trout red blood cells as internal reference standards. Cytometry 1983; 3: 328–31
   PubMedGoogle Scholar
• Baldetorp B., Dalberg M., Hoist U., Lindgren G. Statistical evaluation of cell kinetic data from DNA flow cytometry (FCM) by the EM algorithm. Cytometry 1989; 10: 695–705
   PubMedGoogle Scholar
• Hiddemann W., Schumann J., Andreeff M. Convention on nomenclature for DNA cytometry. Cytometry 1984; 5: 445–6
   Google Scholar
• Baisch H., Gohde W., Linden W. A. Analysis of PCP-data to determine the fraction of cells in the various phases of cell cycle. Radiat Eviron Biophys 1975; 12: 31–9
   PubMed Web of Science ®Google Scholar
• Alvegård T. A., Berg N. O., Baldetorp B. Cellular DNA content and prognosis of high-grade soft tissue sarcoma: the Scandinavian sarcoma group experience. J Clin Oncol 1990; 8: 538–47
   PubMed Web of Science ®Google Scholar
• Decosse J. J., Aiello N. Feulgen hydrolysis: Effect of acid and temperature. J Histochem Cytochem 1966; 14: 601–4
   PubMed Web of Science ®Google Scholar
• Gaub J., Auer G., Zetterberg A. Quantitative cytochemical aspects of a combined Feulgen-naphtol yellow S staining procedure for the simultaneous determination of nuclear and cytoplasmic proteins and DNA in mammalian cells. Exp Cell Res 1975; 92: 323–32
   PubMed Web of Science ®Google Scholar
• Auer G. U., Caspersson T. O., Wallgren A. S. DNA content and survival in mammary carcinoma. Analyt Quant Cytol 1980; 2: 161–5
   PubMedGoogle Scholar
• Baldetorp B., Fernö M, Fallenius A. Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometry. Cytometry 1992; 13: 577–85
   PubMedGoogle Scholar
• Fernö M, Baldetorp B., Ewers S-B. One or multiple samplings for flow cytometric DNA analyses in breast cancer-prognostic implications. Cytometry 1992; 13: 241–9
   PubMedGoogle Scholar
• Sigurdsson H., Baldetorp B., Borg Å. Flow cytometry in primary breast cancer: improving the prognostic value of the fraction of cells in the S-phase by optimal categorisation of cut-off levels. Br J Cancer 1990; 62: 786–90
   PubMedGoogle Scholar